Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.
about
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patientsOral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patientsUpdating the management of sexually transmitted infectionsGenital herpes.Sexually transmitted diseases treatment guidelines, 2015.Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster.Valacyclovir for the treatment of genital herpes.Progress in meeting today's demands in genital herpes: an overview of current management.Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpesPatient satisfaction with care for genital herpes: insights from a global survey.Short-course oral antiviral treatment for recurrent genital herpes.Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses.Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacologyRapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options.2017 European guidelines for the management of genital herpes.2014 UK national guideline for the management of anogenital herpes.Valacyclovir in the treatment of facial herpes simplex virus infection.Valaciclovir as a single dose during prodrome of herpes facialis: a pilot randomized double-blind clinical trial.Single-day famciclovir for the treatment of genital herpes: follow-up results of time to next recurrence and assessment of antiviral resistance.Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.European guideline for the management of genital herpes, 2010.
P2860
Q24194490-EEE8774A-F5A6-4620-9092-A923D5636DBFQ24236379-21EDFDD2-6B0F-4980-816D-62F39A6943C7Q26769634-B3515645-FC14-4D39-90A8-479020AB3D71Q33448071-4FC9A698-7F4A-4B87-9D88-14205CC62914Q34479272-6B6329BF-1C5D-41FE-98BA-0BC860974915Q34551831-C5071891-FAB4-4365-8C5B-26809D658021Q34568338-04E95043-3647-43F5-83D6-877428C49509Q34918299-0FEDF986-23B1-4E3C-8FFD-CBEE64140BF2Q35230156-8A229992-E416-467B-9765-F8FDF583B20BQ35531277-94544836-61CE-408F-AD3B-B7C04FE59725Q35591010-BCBB9E63-15FE-46EF-93FF-4885CAC87CD8Q36170672-0B854478-2FA0-43AF-AE90-6F0B6CCD976DQ36823598-B7C718E2-9828-4C53-9571-171184F59B0DQ37153916-0839253F-C130-402B-BB67-9E51FC240C63Q37771396-81565EBC-8115-4FDD-85CD-E5AE9C8E5EE3Q40072392-710A63E1-D5CF-4580-8965-A45215F95846Q41345018-3E4A2ACE-BF36-421B-A842-33BBD436AAB1Q44157430-5039CBC8-F896-4CC4-8652-A1E49F4DD504Q44282571-60391396-AA80-4F8B-B339-D95847054589Q45206133-00D849A5-4946-459F-B8FC-749999D42F6EQ46475700-8F5101DF-37AF-41DC-AF59-46F956BE929BQ46704016-BEE0217C-8273-4ABA-83A8-AC1B85F9F2D8Q46831784-EA80E03E-DF1F-4459-9BB2-2A45BDB60A96Q50525827-DEA8427F-4CD3-480E-9B55-130027194F5A
P2860
Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Valacyclovir for episodic trea ...... compared with 5-day treatment.
@en
Valacyclovir for episodic trea ...... compared with 5-day treatment.
@nl
type
label
Valacyclovir for episodic trea ...... compared with 5-day treatment.
@en
Valacyclovir for episodic trea ...... compared with 5-day treatment.
@nl
prefLabel
Valacyclovir for episodic trea ...... compared with 5-day treatment.
@en
Valacyclovir for episodic trea ...... compared with 5-day treatment.
@nl
P2860
P356
P1476
Valacyclovir for episodic trea ...... compared with 5-day treatment.
@en
P2093
J Mitchell Miller
Peter A Leone
P2860
P304
P356
10.1086/339326
P407
P577
2002-02-20T00:00:00Z